(1S,2R)-Bortezomib-d5
CAS: 1132709-16-0
Ref. 3D-HVB70916
| 5mg | Discontinued | ||
| 10mg | Discontinued | ||
| 25mg | Discontinued | ||
| 50mg | Discontinued | ||
| 100mg | Discontinued |
Product Information
Name:
(1S,2R)-Bortezomib-d5
Description:
(1S,2R)-Bortezomib-d5 is a modified form of bortezomib that has been radiolabeled with d5. It is an apoptotic agent that inhibits the proteasome pathway and induces apoptosis. Bortezomib-d5 has shown promising results in clinical trials for the treatment of lymphocytic leukemia, chronic lymphocytic leukemia, and multiple myeloma. The drug causes thrombocytopenia as a toxic effect.
Notice:
Our products are intended for lab use only. For any other use, please contact us.
Brand:
Biosynth
Long term storage:
Notes:
Chemical properties
Molecular weight:
389.27 g/mol
Formula:
C19H20D5BN4O4
Purity:
Min. 95%
MDL:
Melting point:
Boiling point:
Flash point:
Density:
Concentration:
EINECS:
Merck:
HS code:
